Stealth Biotherapeutics Headquarters
The links below provide all the necessary information about Stealth Biotherapeutics Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Stealth BioTherapeutics Company Profile - Office Locations, Comp…
- https://craft.co/stealth-biotherapeutics#:~:text=Competitors%20of%20Stealth%20BioTherapeutics%20include%20Affinia%20Therapeutics%2C%20AID,Center%2C%20275%20Grove%20St%20%233%2C%20Auburndale%2C%20Newton.%20
- none
Mitochondrial Medicine Development | Stealth …
- https://www.stealthbt.com/
- Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey with mitochondrial disease and raise awareness of the ...
Contact Us - Stealth BioTherapeutics Inc.
- https://investor.stealthbt.com/websites/stealthbio/English/8000/contact-us.html
- 140 Kendrick Street, Building C-West, Needham, MA 02494 | P: 617.600.6888 | Email Us |
Stealth BioTherapeutics Company Profile - Craft
- https://craft.co/stealth-biotherapeutics
- Stealth BioTherapeutics headquarters is located at Riverside Center, 275 Grove St #3, Auburndale, Newton. Where are Stealth BioTherapeutics offices? Stealth BioTherapeutics has offices in Newton and Needham .
Therapies for Mitochondrial Dysfunction | Stealth …
- https://www.stealthbt.com/our-company/
- Reenie McCarthy is the Chief Executive Officer and a member of the Board of Stealth BioTherapeutics. Reenie is a 20+ year veteran of the investment team of Morningside, Stealth’s principal investor, with extensive experience working with private nonclinical and clinical stage companies developing drugs across a broad spectrum of therapeutic areas.
Stealth BioTherapeutics - Crunchbase Company Profile
- https://www.crunchbase.com/organization/stealth-biotherapeutics
- Phone Number (617)600-6888. Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ ...
Company Stealth BioTherapeutics News, Employees and Funding …
- https://www.topionetworks.com/companies/stealth-biotherapeutics-5b2b703778e00258ddd309d1
- Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. ... Headquarters 275 Grove Street 3-107. Newton, MA 02466. US (617) 600-6888. [email protected]. Web Site. N/A. Milestones Related Companies ...
Stealth BioTherapeutics - Overview, News & Competitors
- https://www.zoominfo.com/c/stealth-biotherapeutics-inc/353796936
- Stealth BioTherapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases i. nvolving mitochondrial dysfunction. Established in 2006, Stealth BioTherapeutics is headquartered in Newton, Massachusetts, United States. Read More. Headquarters:
Working at Stealth BioTherapeutics | Glassdoor
- https://www.glassdoor.com/Overview/Working-at-Stealth-BioTherapeutics-EI_IE1828327.11,34.htm
- Headquarters: Newton, MA. Size: 51 to 200 Employees. Type: Company - Public (MITO) ... Glassdoor gives you an inside look at what it's like to work at Stealth BioTherapeutics, including salaries, reviews, office photos, and more. This is the Stealth BioTherapeutics company profile. All content is posted anonymously by employees working at ...
Stealth BioTherapeutics Corp - Company Profile and …
- https://www.bloomberg.com/profile/company/S1BA:GR
- Company profile page for Stealth BioTherapeutics Corp including stock price, company news, press releases, executives, board members, and contact information
Stealth BioTherapeutics | LinkedIn
- https://www.linkedin.com/company/stealth-biotherapeutics
- Stealth BioTherapeutics | 4,882 followers on LinkedIn. Committed to Innovation in Mitochondrial Therapies | Our Mission Stealth BioTherapeutics is an innovative biopharmaceutical company ...
Stealth BioTherapeutics Company Profile: Stock Performance
- https://pitchbook.com/profiles/company/64697-14
- Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and. Drug Discovery. Needham, MA. 38 …
Stealth BioTherapeutics Receives Orphan Drug Designation from …
- https://www.upmatters.com/business/press-releases/cision/20220512NE55401/stealth-biotherapeutics-receives-orphan-drug-designation-from-fda-for-elamipretide-for-treatment-of-duchenne-muscular-dystrophy/
- BOSTON, May 12, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel ...
Stealth BioTherapeutics Corp. - Company Profiles - BCIQ
- https://profiles.biocentury.com/companies/stealth_biotherapeutics_corp
- ...Shares of Stealth BioTherapeutics sank 65% to $4.75 on Friday after the company announced a Phase III.....Total Fatigue Scores in the Phase III MMPOWER-3 trial. During an investor call on Monday, Stealth BioTherapeutics Corp.....Story Hits $930M High Note” ). Lauren Martz, Associate Editor Subcutaneous elamipretide (MTP-131, bendavia, ocuvia, ss-31) Alexion Pharmaceuticals …
Stealth BioTherapeutics - Longevity List
- https://longevitylist.com/company/stealth-biotherapeutics/
- Stealth BioTherapeutics is an innovative biopharmaceutical company committed to bringing patients mitochondrial targeted therapies to treat both common and rare diseases. Driven by a desire to help patients with unmet treatment needs, our team collaborates with well-recognized institutions, physicians and scientists to develop the next ...
Stealth BioTherapeutics Stock Forecast, Price & News
- https://www.marketbeat.com/stocks/NASDAQ/MITO/
- Stealth BioTherapeutics' stock was trading at $1.5887 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MITO shares have decreased by 88.5% and is now trading at $0.1825. View which stocks have been most impacted by COVID-19.
Did you find out everything you wanted about Stealth Biotherapeutics Headquarters?
We are sure that the information collected for you about Stealth Biotherapeutics Headquarters turned out to be more than enough.
